Skip to content

A retrospective study on the real world of Xuebijing Injection

A retrospective study on the real world of Xuebijing Injection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045106
Enrollment
Unknown
Registered
2021-04-06
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sponsors

Department of Pharmacy, Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.All the people who were treated with Xuebijing and non-Xuebijing groups who had the same diagnosis (the main diagnosis disease was the same) and treatment characteristics. 2.The patients who met the diagnosis of sepsis or the first three diseases of main diagnosis are the same, treated with Xuebijing after diagnosis or non-Xuebijing group with the same diagnosis and treatment characteristics.

Exclusion criteria

Exclusion criteria: The missing rate of case diagnosis, course of disease, medical advice, examination, treatment, combined medication, cost, etc. >= 20%.

Design outcomes

Primary

MeasureTime frame
hospital mortality;

Secondary

MeasureTime frame
SOFA score;hospital stay;Characteristics of population using Xuebijing;Incidence of adverse events;Incidence of adverse reactions of Xuebijing;

Countries

China

Contacts

Public ContactLai Weihua

Department of Pharmacy, Guangdong Provincial People's Hospital

laiweihuax@163.com+86 13570042336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026